Sander J. H. van Deventer

28.1k total citations · 7 hit papers
269 papers, 22.1k citations indexed

About

Sander J. H. van Deventer is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Sander J. H. van Deventer has authored 269 papers receiving a total of 22.1k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Immunology, 87 papers in Epidemiology and 80 papers in Genetics. Recurrent topics in Sander J. H. van Deventer's work include Immune Response and Inflammation (70 papers), Inflammatory Bowel Disease (69 papers) and Microscopic Colitis (27 papers). Sander J. H. van Deventer is often cited by papers focused on Immune Response and Inflammation (70 papers), Inflammatory Bowel Disease (69 papers) and Microscopic Colitis (27 papers). Sander J. H. van Deventer collaborates with scholars based in Netherlands, United States and Vietnam. Sander J. H. van Deventer's co-authors include Tom van der Poll, Stephen B. Hanauer, Kimberly L. DeWoody, Daniel H. Present, T Schaible, Maikel P. Peppelenbosch, Paul Rutgeerts, Stephan R. Targan, Gijs R. van den Brink and R. A. van Hogezand and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Sander J. H. van Deventer

268 papers receiving 21.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

1997 2.5k citations Sander J. H. van Deventer et al. profile →
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

1999 2.0k citations Sander J. H. van Deventer et al. profile →
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

1995 886 citations Sander J. H. van Deventer, Daan W. Hommes et al. profile →
Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

1999 875 citations Sander J. H. van Deventer et al. profile →
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease

2006 571 citations Henri Braat, Daniël W. Hommes et al. profile →
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease

2003 555 citations Henri Braat, Gijs R. van den Brink et al. profile →
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects

1990 514 citations Tom van der Poll, Hugo Ten Cate et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sander J. H. van Deventer Netherlands	72	7.7k	7.7k	7.3k	4.9k	4.0k	269	22.1k
Toshifumi Hibi∥ Japan	81	8.3k 1.1×	9.9k 1.3×	7.1k 1.0×	7.6k 1.5×	5.3k 1.3×	788	26.6k
Lloyd Mayer United States	64	6.8k 0.9×	9.4k 1.2×	7.7k 1.1×	4.0k 0.8×	2.3k 0.6×	184	19.1k
Thomas T. MacDonald United Kingdom	83	4.5k 0.6×	7.2k 0.9×	10.1k 1.4×	4.5k 0.9×	5.6k 1.4×	320	23.8k
Stephan R. Targan United States	90	12.5k 1.6×	18.3k 2.4×	11.5k 1.6×	6.0k 1.2×	4.4k 1.1×	434	31.0k
Antoine Cortot France	62	8.3k 1.1×	11.7k 1.5×	4.7k 0.6×	6.0k 1.2×	3.2k 0.8×	275	19.3k
María T. Abreu United States	76	7.3k 0.9×	10.1k 1.3×	6.4k 0.9×	5.0k 1.0×	4.8k 1.2×	378	21.4k
Daniel Rachmilewitz Israel	52	10.5k 1.4×	13.7k 1.8×	5.2k 0.7×	6.2k 1.3×	2.6k 0.7×	200	21.5k
Marc Ferrante Belgium	64	8.9k 1.1×	12.4k 1.6×	4.7k 0.6×	5.3k 1.1×	4.6k 1.1×	543	21.4k
Claudio Fiocchi United States	64	3.8k 0.5×	7.1k 0.9×	5.5k 0.8×	3.8k 0.8×	3.8k 1.0×	248	15.6k
Charles O. Elson United States	76	3.9k 0.5×	6.1k 0.8×	12.6k 1.7×	3.3k 0.7×	6.2k 1.5×	218	23.7k

Countries citing papers authored by Sander J. H. van Deventer

Since Specialization

Citations

This map shows the geographic impact of Sander J. H. van Deventer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander J. H. van Deventer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander J. H. van Deventer more than expected).

Fields of papers citing papers by Sander J. H. van Deventer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander J. H. van Deventer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander J. H. van Deventer. The network helps show where Sander J. H. van Deventer may publish in the future.

Co-authorship network of co-authors of Sander J. H. van Deventer

This figure shows the co-authorship network connecting the top 25 collaborators of Sander J. H. van Deventer. A scholar is included among the top collaborators of Sander J. H. van Deventer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander J. H. van Deventer. Sander J. H. van Deventer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hommes, Daniël W. & Sander J. H. van Deventer. (2003). Targeting tumor necrosis factor-α in inflammatory bowel disease. Current Opinion in Gastroenterology. 19(4). 350–357. 7 indexed citations

2.

Velde, Anje A. te, Yvette van Kooyk, Henri Braat, et al.. (2002). Increased expression of DC‐SIGN⁺IL‐12⁺IL‐18⁺ and CD83⁺IL‐12^–IL‐18^– dendritic cell populations in the colonic mucosa of patients with Crohn's disease. European Journal of Immunology. 33(1). 143–151. 117 indexed citations

3.

Kwikkers, Karin L., Anje A. te Velde, Sander J. H. van Deventer, et al.. (2002). Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice. Journal of Clinical Investigation. 110(10). 1539–1548. 90 indexed citations

4.

Kwikkers, Karin L., Anje A. te Velde, Sander J. H. van Deventer, et al.. (2002). Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice. Journal of Clinical Investigation. 110(10). 1539–1548. 79 indexed citations

5.

Branger, Judith, Bernt van den Blink, Sebastiaan Weijer, et al.. (2002). Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia. The Journal of Immunology. 168(8). 4070–4077. 203 indexed citations

6.

Ponsioen, Cyriel Y., et al.. (2001). A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects. European Journal of Internal Medicine. 12(6). 518–521. 6 indexed citations

7.

Verbon, Annelies, Pascale E. P. Dekkers, Tessa ten Hove, et al.. (2001). IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans. The Journal of Immunology. 166(5). 3599–3605. 102 indexed citations

8.

Olszyna, Dariusz P., Sandrine Florquin, Miguel E. Sewnath, et al.. (2001). CXC Chemokine Receptor 2 Contributes to Host Defense in Murine Urinary Tract Infection. The Journal of Infectious Diseases. 184(3). 301–307. 46 indexed citations

9.

Blink, Bernt van den, Nicole P. Juffermans, Tessa ten Hove, et al.. (2001). p38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release by Macrophages In Vitro and During Infection In Vivo. The Journal of Immunology. 166(1). 582–587. 97 indexed citations

10.

Rijneveld, Anita W., Sandrine Florquin, Judith Branger, et al.. (2001). TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia. The Journal of Immunology. 167(9). 5240–5246. 103 indexed citations

11.

Juffermans, Nicole P., Annelies Verbon, John T. Belisle, et al.. (2000). Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung. American Journal of Respiratory and Critical Care Medicine. 162(2). 486–489. 28 indexed citations

12.

Schultz, Marc J., et al.. (2000). The effect ofPseudomonasexotoxin A on cytokine production in whole blood exposed toPseudomonas aeruginosa. FEMS Immunology & Medical Microbiology. 29(3). 227–232. 25 indexed citations

13.

Brink, Gijs R. van den, Fiebo J. ten Kate, Cyriel Y. Ponsioen, et al.. (2000). Expression and Activation of NF-κB in the Antrum of the Human Stomach. The Journal of Immunology. 164(6). 3353–3359. 73 indexed citations

14.

Lauw, Fanny N., Dasja Pajkrt, C. Erik Hack, et al.. (2000). Proinflammatory Effects of IL-10 During Human Endotoxemia. The Journal of Immunology. 165(5). 2783–2789. 253 indexed citations

15.

Juffermans, Nicole P., Annelies Verbon, Sander J. H. van Deventer, et al.. (1998). Tumor Necrosis Factor and Interleukin-1 Inhibitors as Markers of Disease Activity of Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 157(4). 1328–1331. 71 indexed citations

16.

Camoglio, Luisa, Anje A. te Velde, A. J. Tigges, Pranab K. Das, & Sander J. H. van Deventer. (1998). Altered expression of interferon-γ and interleukin-4 in inflammatory bowel disease. Inflammatory Bowel Diseases. 4(4). 285–290. 105 indexed citations

17.

Camoglio, Luisa, Anje A. te Velde, A. J. Tigges, Pranab K. Das, & Sander J. H. van Deventer. (1998). Altered Expression of Interferon-γ and Interleukin-4 in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 4(4). 285–290. 67 indexed citations

18.

Poll, Tom van der, Arnaud Marchant, & Sander J. H. van Deventer. (1997). The role of interleukin-10 in the pathogenesis of bacterial infection. Clinical Microbiology and Infection. 3(6). 605–607. 20 indexed citations

19.

Poll, Tom van der, J. Jansen, Hugo Ten Cate, et al.. (1996). Interleukin 10 Release During Endotoxaemia in Chimpanzees: Role of Platelet‐Activating Factor and Interleukin 6. Scandinavian Journal of Immunology. 43(1). 122–125. 7 indexed citations

20.

Deventer, Sander J. H. van, et al.. (1995). Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.. PubMed. 90(6). 893–900. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact